Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000335626 | TCF20-201 | 6237 | XM_011530354 | ENSP00000335561 | 1938 (aa) | XP_011528656 | Q9UGU0 |
ENST00000404876 | TCF20-203 | 1058 | - | ENSP00000385531 | 250 (aa) | - | A9JX13 |
ENST00000515426 | TCF20-204 | 633 | - | ENSP00000458948 | 153 (aa) | - | I3L1M7 |
ENST00000359486 | TCF20-202 | 7410 | XM_005261722 | ENSP00000352463 | 1960 (aa) | XP_005261779 | Q9UGU0 |
ensgID | Trait | pValue | Pubmed ID |
---|---|---|---|
ENSG00000100207 | Cholesterol | 8.7080000E-005 | - |
ENSG00000100207 | Interleukin-8 | 7.2670000E-005 | - |
ENSG00000100207 | Insulin-Like Growth Factor I | 3.9020000E-005 | - |
ENSG00000100207 | Insulin-Like Growth Factor I | 4.0940000E-005 | - |
ENSG00000100207 | Insulin-Like Growth Factor I | 5.2760000E-005 | - |
ENSG00000100207 | Hypertension | 3.2335514E-005 | - |
ENSG00000100207 | Cognition | 1E-6 | 25644384 |
ENSG00000100207 | Body Mass Index | 7E-6 | 25673413 |
ENSG00000100207 | Schizophrenia | 2E-9 | 25056061 |
ENSG00000100207 | Schizophrenia | 6E-10 | 26198764 |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000100207 | rs760648 | 22 | 42175022 | A | Autism spectrum disorder or schizophrenia | 28540026 | [1.04-1.08] | 1.06 | EFO_0000692|EFO_0003756 |
ENSG00000100207 | rs6002655 | 22 | 42207808 | T | Schizophrenia | 25056061 | [1.044-1.088] | 1.066 | EFO_0000692 |
ENSG00000100207 | rs134882 | 22 | 42274959 | ? | Bipolar disorder and schizophrenia | 20889312 | [NR] | 1.2196 | EFO_0000677 |
ENSG00000100207 | rs6002655 | 22 | 42207808 | T | Schizophrenia | 26198764 | [NR] | 1.07 | EFO_0000692 |
ENSG00000100207 | rs2413685 | 22 | 42321584 | A | Cognitive performance | 30038396 | [0.01-0.022] unit decrease | 0.0159 | EFO_0008354 |
ENSG00000100207 | rs2413685 | 22 | 42321584 | A | Cognitive performance (MTAG) | 30038396 | [0.0083-0.0173] unit decrease | 0.0128 | EFO_0008354 |
ENSG00000100207 | rs4822112 | 22 | 42335534 | ? | Surgical necrotising enterocolitis in extremely premature birth | 29538362 | EFO_0003928|EFO_0003917 | ||
ENSG00000100207 | rs187166731 | 22 | 42270020 | C | Interleukin-1-receptor antagonist levels | 27989323 | [0.13-0.33] SD units increase | 0.2325 | EFO_0004754 |
ENSG00000100207 | rs5758659 | 22 | 42225997 | ? | Cognitive function | 25644384 | [0.016-0.038] unit decrease | 0.027 | EFO_0004337 |
ENSG00000100207 | rs134871 | 22 | 42256710 | ? | General cognitive ability | 29844566 | z-score increase | 5.178 | EFO_0004337 |
ENSG00000100207 | rs4822112 | 22 | 42335534 | T | Intelligence | 29942086 | z-score decrease | 5.943 | EFO_0004337 |
ENSG00000100207 | rs6002655 | 22 | 42207808 | ? | Schizophrenia | 29483656 | [1.06-1.10] | 1.0775862 | EFO_0000692 |
ENSG00000100207 | rs5758667 | 22 | 42237198 | A | Red vs. brown/black hair color | 30531825 | NR | 39.43 | EFO_0003924 |
ENSG00000100207 | rs73169175 | 22 | 42325368 | ? | Systolic blood pressure | 30595370 | EFO_0006335 | ||
ENSG00000100207 | rs4822107 | 22 | 42308828 | ? | Morning person | 30595370 | EFO_0008328 | ||
ENSG00000100207 | rs4822108 | 22 | 42309864 | ? | Lung function (FVC) | 30595370 | EFO_0004312 | ||
ENSG00000100207 | rs762995 | 22 | 42276118 | ? | Smoking status | 30595370 | EFO_0006527 | ||
ENSG00000100207 | rs6002676 | 22 | 42301210 | A | Risk-taking tendency (4-domain principal component model) | 30643258 | [0.0096-0.02] unit increase | 0.014796305 | EFO_0008579 |
ENSG00000100207 | rs760648 | 22 | 42175022 | A | Schizophrenia | 30285260 | [1.06-1.1] | 1.079 | EFO_0000692 |
ENSG00000100207 | rs6002655 | 22 | 42207808 | T | Schizophrenia | 30285260 | [1.04-1.08] | 1.059 | EFO_0000692 |
ENSG00000100207 | rs4822103 | 22 | 42302568 | C | Smoking initiation (ever regular vs never regular) (MTAG) | 30643251 | [0.0055-0.0099] unit decrease | 0.00770318 | EFO_0006527 |
ENSG00000100207 | rs4822102 | 22 | 42302424 | T | Smoking initiation (ever regular vs never regular) | 30643251 | [0.011-0.022] unit decrease | 0.016542807 | EFO_0006527 |
ENSG00000100207 | rs762995 | 22 | 42276118 | A | Chronotype | 30696823 | [0.0083-0.0149] unit decrease | 0.0115978 | EFO_0008328 |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0003677 | DNA binding | 10995766. | NAS | Function |
GO:0003700 | DNA-binding transcription factor activity | 21873635. | IBA | Function |
GO:0003713 | transcription coactivator activity | 10995766. | NAS | Function |
GO:0003723 | RNA binding | 22658674. | HDA | Function |
GO:0005515 | protein binding | 17913746. | IPI | Function |
GO:0005634 | nucleus | 21873635. | IBA | Component |
GO:0005634 | nucleus | 10995766. | NAS | Component |
GO:0005654 | nucleoplasm | - | IDA | Component |
GO:0006355 | regulation of transcription, DNA-templated | 10995766. | NAS | Process |
GO:0016604 | nuclear body | - | IDA | Component |
GO:0044212 | transcription regulatory region DNA binding | 21873635. | IBA | Function |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 21873635. | IBA | Process |
GO:0046872 | metal ion binding | - | IEA | Function |